AoBiome

AOBiome Therapeutics, Inc. is a life sciences company located in Cambridge, Massachusetts. Founded in 2012, the company employs 15 people and generates approximately $2.5 million in annual revenue. AOBiome is dedicated to revolutionizing human health through the development of microbiome-based therapies. The company focuses on creating treatments for a range of inflammatory conditions, both locally and systemically. These include acne vulgaris, pediatric and adult eczema (atopic dermatitis), episodic migraines, and allergic rhinitis. AOBiome's therapeutic pipeline encompasses multiple clinical-stage programs, with some already having completed Phase 2 studies. AOBiome's approach centers on harnessing the power of the microbiome to address these inflammatory conditions. Their research and development efforts aim to create innovative therapies that leverage the beneficial properties of the microbiome to improve patient outcomes. The company is actively pursuing clinical trials for several of their therapeutic candidates, demonstrating their commitment to advancing microbiome-based medicine. For more information about AOBiome Therapeutics, Inc. and their groundbreaking research, please visit their website at aobiome.com.